Log in to your Inderes Free account to see all free content on this page.
Lumito
0.02 SEK
-6.25 %
Less than 1K followers
LUMITO
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-6.25 %
-61.54 %
-81.80 %
-92.97 %
-92.98 %
-90.73 %
-97.08 %
-98.92 %
-96.92 %
Lumito is a Swedish company that develops and markets systems for tissue and biomarker analysis in digital pathology, built on upconverting nanoparticle technology. The company targets healthcare facilities, research and the pharmaceutical sector. The company was formed in 2010 as a spinoff from a research group at Lund University's Department of Atomic Physics and Laser Center. Lumito is headquartered in Lund.
Read moreMarket cap
25.81M SEK
Turnover
149.52K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue K
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20.2.
2026
Annual report '25
7.5.
2026
General meeting '26
7.5.
2026
Interim report Q1'26
All
Press releases
ShowingAll content types
Lumito’s technology enables quantification of low abundant cells
Lumito strengthens its international presence and participates in Digital Pathology & AI Congress Europe
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio